ZACKS RESEARCH

FUNDS

PORTFOLIO

BROKER RESEARCH

MARKETS

SCREENING

EDUCATION

SERVICES

Earnings

EPS Surprises

Mutual Funds

Options

My Account

Help

Zacks #1 Rank
See how a purely mathematical analysis of earnings estimate revisions returns over 27% per year on average. Click Here to Learn More.

Quote:

Search for Ticker

Free Membership

Search:

DGX: Quest Diagnostics Inc - Full Company Report Enter Ticker:

Quote	Estimates	Charts	Company Reports	News	Financials

Full Company Report \| Estimates \| Brokerage Recommendations \| Comparison to Industry \| Insiders \| Brokerage Reports \| Zacks Equity Research \| Annual Report

QUEST DIAGNOSTICS INC (NYSE)
DGX	58.85	N/A	(N/A%)	Vol. 0	N/A ET

Quest Diagnostics Inc., is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care.

General Information

QUEST DIAGNOSTC

3 Giralda Farms Madison, NJ 07940 Phone: 800-222-0446 Fax: 201 462-4169 Web: www.questdiagnostics.com Email: investor@questdiagnostics.com

Industry	MED-OUTP/HM CRE
Sector:	Medical

Fiscal Year End	December
Last Reported Quarter	09/30/09
Next EPS Date	01/25/2010

Price and Volume Information

Zacks Rank
Yesterday's Close	58.85
52 Week High	59.57
52 Week Low	42.36
Beta	0.40
20 Day Moving Average	1,224,246.63
Target Price Consensus	63.7

% Price Change
4 Week	3.25
12 Week	6.09
YTD	12.02

% Price Change Relative to S&P 500
4 Week	2.13
12 Week	0.02
YTD	-7.29

Share Information
Shares Outstanding (millions)	185.75
Market Capitalization (millions)	10,801.19
Short Ratio	3.47
Last Split Date	06/21/2005

Dividend Information
Dividend Yield	0.69%
Annual Dividend	$0.40
Payout Ratio	0.11
Change in Payout Ratio	-0.02
Last Dividend Payout / Amount	09/30/2009 / $0.10

EPS Information
Current Quarter EPS Consensus Estimate	0.96
Current Year EPS Consensus Estimate	3.85
Estimated Long-Term EPS Growth Rate	12.40
Next EPS Report Date	01/25/2010

Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell)	2.18
30 Days Ago	2.10
60 Days Ago	2.10
90 Days Ago	1.90

Fundamental Ratios

P/E
Current FY Estimate:	15.14
Trailing 12 Months:	15.38
PEG Ratio	1.22

EPS Growth
vs. Previous Year	18.60%
vs. Previous Quarter	2.00%

Sales Growth
vs. Previous Year	3.87%
vs. Previous Quarter:	-0.24%

Price Ratios
Price/Book	2.74
Price/Cash Flow	12.68
Price / Sales	1.46

ROE
09/30/09	19.31
06/30/09	18.95
03/31/09	18.42

ROA
09/30/09	8.60
06/30/09	8.27
03/31/09	7.90

Current Ratio
09/30/09	1.48
06/30/09	1.31
03/31/09	1.17

Quick Ratio
09/30/09	1.40
06/30/09	1.23
03/31/09	1.10

Operating Margin
09/30/09	9.67
06/30/09	9.45
03/31/09	9.20

Net Margin
09/30/09	16.18
06/30/09	15.44
03/31/09	14.77

Pre-Tax Margin
09/30/09	16.18
06/30/09	15.44
03/31/09	14.77

Book Value
09/30/09	21.20
06/30/09	20.31
03/31/09	18.53

Inventory Turnover
09/30/09	49.17
06/30/09	46.50
03/31/09	44.08

Debt-to-Equity
09/30/09	0.73
06/30/09	0.76
03/31/09	0.87

Debt to Capital
09/30/09	42.22
06/30/09	43.32
03/31/09	46.56


About Zacks \| Advertise \| Media \| Careers \| Contact Us \| Help Disclaimer \| Privacy Policy \| Sitemap NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed. Copyright 2009 Zacks Investment Research